Bergan Kdv Wealth Management, LLC Clovis Oncology, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$1.43 - $3.14 $71 - $157	-50 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$2.7 - $4.76 $135 - $238	-50 Reduced 50.0%	50 $0
Q2 2021 Aug 10, 2021	BUY	$5.02 - $7.05 $501 - $705	100 New	100 $1,000
Q4 2020 Feb 04, 2021	SELL	$4.13 - $6.41 $413 - $641	-100 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$4.82 - $7.72 $67,745 - $108,504	-14,055 Reduced 99.29%	100 $1,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $9.69 $59,813 - $101,861	10,512 Added 288.55%	14,155 $96,000
Q1 2020 Apr 24, 2020	BUY	$3.77 - $11.0 $13,734 - $40,073	3,643 New	3,643 $23,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.